{"entity":{"id":"elisabeth-schorb","kind":"person","name":"Elisabeth Schorb","aka":[],"tldr":"Internal medicine oncologist who directs the Comprehensive Cancer Center Freiburg and heads its clinical trials unit.","summary":"PD Dr Elisabeth Schorb is Direktorin und Sprecherin of the Tumorzentrum Freiburg - CCCF, the certified oncology centre of excellence of the University Medical Center Freiburg. She is a senior physician in the Department of Internal Medicine I and heads its clinical trials centre and early clinical trials unit. The CCCF executive board she leads includes Justus Duyster (medical oncology), Stefan Fichtner-Feigl (surgical oncology), Melanie Börries (data-driven medicine), Michael Quante (prevention and patient participation) and Andreas Rimner (scientific director since 2025).","asOf":"2026-09-10","links":[{"label":"Source: CCCF leadership page","url":"https://www.uniklinik-freiburg.de/cccf/ueber-uns/leitung.html"}],"tags":["leadership","clinician-scientist","cancer-centre"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["ccc-freiburg"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":["lancet-haematology","blood-advances"],"dependsOn":[],"notes":[],"role":"Director and Spokesperson of the Tumorzentrum Freiburg - CCCF","institutionId":"ccc-freiburg","specialisms":["Haematology and oncology","Clinical trials","Cancer centre leadership"],"profiles":[{"label":"Institution leadership page","url":"https://www.uniklinik-freiburg.de/cccf/ueber-uns/leitung.html"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Schorb+E%5BAuthor%5D"}],"papers":[{"title":"High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm, phase 2 trial","journal":"The Lancet Haematology","year":2024,"doi":"10.1016/s2352-3026(23)00371-x"},{"title":"High-dose chemotherapy and autologous stem cell transplant in elderly patients with primary CNS lymphoma: a pilot study","journal":"Blood Advances","year":2020,"doi":"10.1182/bloodadvances.2020002064"},{"title":"Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B‐cell lymphoma of the central nervous system – an international study of feasibility and efficacy in routine clinical practice","journal":"British Journal of Haematology","year":2020,"doi":"10.1111/bjh.16451"}],"orcid":"0000-0003-0948-2125"},"route":"/people/elisabeth-schorb/","neighbours":{"institution":[{"id":"ccc-freiburg","kind":"institution","name":"Comprehensive Cancer Center Freiburg (CCCF)","route":"/institutions/ccc-freiburg/"}],"journal":[{"id":"blood-advances","kind":"journal","name":"Blood Advances","route":"/journals/blood-advances/"},{"id":"lancet-haematology","kind":"journal","name":"The Lancet Haematology","route":"/journals/lancet-haematology/"}]}}